FATE
Price
$1.25
Change
-$0.03 (-2.34%)
Updated
Apr 28 closing price
Capitalization
143.25M
One day until earnings call
TCRX
Price
$1.60
Change
-$0.00 (-0.00%)
Updated
Apr 28 closing price
Capitalization
90.55M
14 days until earnings call
Ad is loading...

FATE vs TCRX

Header iconFATE vs TCRX Comparison
Open Charts FATE vs TCRXBanner chart's image
Fate Therapeutics
Price$1.25
Change-$0.03 (-2.34%)
Volume$1.14M
Capitalization143.25M
TScan Therapeutics
Price$1.60
Change-$0.00 (-0.00%)
Volume$260.19K
Capitalization90.55M
FATE vs TCRX Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. TCRX commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Buy and TCRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (FATE: $1.25 vs. TCRX: $1.60)
Brand notoriety: FATE and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 48% vs. TCRX: 55%
Market capitalization -- FATE: $143.25M vs. TCRX: $90.55M
FATE [@Biotechnology] is valued at $143.25M. TCRX’s [@Biotechnology] market capitalization is $90.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 0 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 0 green, 5 red.
According to our system of comparison, FATE is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 5 TA indicator(s) are bullish while TCRX’s TA Score has 3 bullish TA indicator(s).

  • FATE’s TA Score: 5 bullish, 5 bearish.
  • TCRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, FATE is a better buy in the short-term than TCRX.

Price Growth

FATE (@Biotechnology) experienced а 0.00% price change this week, while TCRX (@Biotechnology) price change was +4.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.96%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -9.88%.

Reported Earning Dates

FATE is expected to report earnings on Jul 30, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+7.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($143M) has a higher market cap than TCRX($90.5M). FATE YTD gains are higher at: -24.242 vs. TCRX (-47.368). TCRX has higher annual earnings (EBITDA): -119.74M vs. FATE (-176.58M). TCRX (290M) and FATE (279M) have equal amount of cash in the bank . FATE has less debt than TCRX: FATE (85.3M) vs TCRX (97.4M). FATE has higher revenues than TCRX: FATE (13.6M) vs TCRX (2.82M).
FATETCRXFATE / TCRX
Capitalization143M90.5M158%
EBITDA-176.58M-119.74M147%
Gain YTD-24.242-47.36851%
P/E RatioN/AN/A-
Revenue13.6M2.82M483%
Total Cash279M290M96%
Total Debt85.3M97.4M88%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATETCRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMGZY25.370.77
+3.13%
Smiths Group Plc
KYOCY11.990.19
+1.61%
Kyocera Corp.
HECOF0.02N/A
N/A
GLOBAL HELIUM CORP
DASTY36.36-0.71
-1.92%
Dassault Systemes SA
IBATF0.38-0.04
-9.52%
International Battery Metals Ltd.

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-2.34%
ALLO - FATE
55%
Loosely correlated
+1.29%
NTLA - FATE
55%
Loosely correlated
+2.05%
CRBU - FATE
52%
Loosely correlated
-0.30%
CRSP - FATE
51%
Loosely correlated
-1.02%
RXRX - FATE
48%
Loosely correlated
+1.92%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with PRME. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
N/A
PRME - TCRX
46%
Loosely correlated
-1.78%
FATE - TCRX
44%
Loosely correlated
-2.34%
IMNM - TCRX
43%
Loosely correlated
+2.14%
SYRE - TCRX
43%
Loosely correlated
+3.82%
IDYA - TCRX
42%
Loosely correlated
+3.95%
More